Amrize Ltd (NYSE:AMRZ) Short Interest Update

Key Points

• Short interest fell 21.7% to 6,288,992 shares as of March 13, representing about 1.1% of the stock and a short-interest ratio of 1.7 days, signaling reduced short pressure.
• Insider buying accelerated: CEO Jan Philipp Jenisch purchased 60,000 shares for $3.48M and CTO Roald Brouwer bought 3,000 shares, with insiders acquiring 77,834 shares (~$4.51M) over the last three months and now owning 0.54% of the company.
• Analysts remain broadly positive with a MarketBeat consensus of Moderate Buy and a $64.14 target; Amrize also reported Q earnings of $0.62/share (beat) and announced a $0.44 dividend payable May 4.

Amrize Ltd (NYSE:AMRZ - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 6,288,992 shares, a decline of 21.7% from the February 26th total of 8,035,260 shares. Currently, 1.1% of the company's stock are short sold. Based on an average trading volume of 3,774,537 shares, the short-interest ratio is presently 1.7 days.

Insider Activity

In related news, CEO Jan Philipp Jenisch purchased 60,000 shares of the business's stock in a transaction on Friday, March 6th. The shares were bought at an average price of $58.05 per share, for a total transaction of $3,483,000.00. Following the acquisition, the chief executive officer directly owned 1,703,582 shares in the company, valued at $98,892,935.10. This trade represents a 3.65% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CTO Roald Brouwer bought 3,000 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The shares were purchased at an average price of $58.72 per share, for a total transaction of $176,160.00. Following the completion of the purchase, the chief technology officer directly owned 16,257 shares of the company's stock, valued at approximately $954,611.04. This trade represents a 22.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 77,834 shares of company stock worth $4,511,344 over the last three months. Company insiders own 0.54% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the company. MCF Advisors LLC purchased a new position in Amrize in the fourth quarter valued at approximately $27,000. State of Wyoming acquired a new stake in Amrize during the 3rd quarter valued at $32,000. Basepoint Wealth LLC purchased a new stake in shares of Amrize during the fourth quarter worth about $33,000. Laurel Wealth Advisors LLC purchased a new stake in Amrize during the 4th quarter worth approximately $34,000. Finally, US Bancorp DE bought a new stake in shares of Amrize in the third quarter worth $38,000.

Analyst Upgrades and Downgrades

AMRZ has been the topic of several recent analyst reports. Weiss Ratings upgraded shares of Amrize from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, March 18th. Citigroup increased their target price on shares of Amrize from $63.00 to $67.00 and gave the stock a "buy" rating in a research note on Thursday, January 8th. UBS Group boosted their price objective on shares of Amrize from $53.00 to $57.00 and gave the company a "neutral" rating in a research note on Thursday, January 8th. Royal Bank Of Canada boosted their target price on Amrize from $60.00 to $61.00 and gave the stock a "sector perform" rating in a research report on Thursday, February 19th. Finally, Wells Fargo & Company increased their price target on shares of Amrize from $59.00 to $66.00 and gave the company an "overweight" rating in a report on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Amrize presently has a consensus rating of "Moderate Buy" and a consensus price target of $64.14.

Amrize Stock Performance

Amrize stock opened at $53.89 on Friday. The stock has a fifty day moving average of $57.78 and a two-hundred day moving average of $53.84. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The company has a market capitalization of $29.80 billion and a price-to-earnings ratio of 21.90. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion during the quarter, compared to analysts' expectations of $2.95 billion. The business's revenue for the quarter was down .4% on a year-over-year basis.

Amrize Dividend Announcement

The firm also recently announced a dividend, which will be paid on Monday, May 4th. Investors of record on Monday, April 27th will be paid a $0.44 dividend. The ex-dividend date is Friday, April 24th.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.